BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs7903146, FGF21, cell-cell adhesion, Lung cancer, Retina, Anticancer prodrugs, Lipitor)
Bookmark Forward

QuickView for anti-hypertensives (compound)


Genetic Markers

Most Correlated Genes

  1. FOS
  2. ATF3
  3. ACE
  4. CYP1A1
  5. CYP51A1
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. regulation of nitrogen compound metabolic process
  2. PILON_KLF1_TARGETS_DN
  3. organic cyclic compound binding
  4. heterocyclic compound binding
  5. response to organic substance
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Brain cortices from reserpine-treated, corticosterone-treated or olfactory bulbectomized rats
  2. Endometrium gene expression of postmenopausal women treated 21d with different hormones
  3. Cerebral capillary gene expression in stroke prone spontaneously hypertensive rats (SHRSP)
  4. Breast tumor biopsies before and after hydralazine and valproate treatment
  5. Liver Pharmacology and Xenobiotic Response Repertoire
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Use of fixed-dose combinations for cardiovascular indications from 2018 to 2023: a nationwide popula…
  2. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and …
  3. Effects of Combined Anti-Hypertensive and Statin Treatment on Memory, Fear Extinction, Adult Neuroge…
  4. Antihypertensives in Pregnancy.
  5. Drug Interactions with Antihypertensives.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Spermidine Anti-Hypertension Study
  2. Sacubitril-valsartan Versus Usual Anti-hypertensives in LVAD
  3. AI for Anti-hypertensive Medication Titration
  4. Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study
  5. Response to Anti-hypertensives in Pregnant and Postpartum Patients
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.